G.Barekat Pharm (XTEH:BRKT1) Research & Development : IRR Mil (TTM As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. G.Barekat Pharm's Research & Development for the six months ended in Mar. 2017 was IRR5,085 Mil. G.Barekat Pharm does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Mar. 2017.

G.Barekat Pharm Research & Development Historical Data

The historical data trend for G.Barekat Pharm's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Research & Development Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Research & Development

11,937.00

5,085.00

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Research & Development	11,937.00	5,085.00

G.Barekat Pharm Research & Development Calculation

This is the expense the company spent on research and development.

G.Barekat Pharm (XTEH:BRKT1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

G.Barekat Pharm Research & Development Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines